Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655064
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PETCT Imaging Evaluations
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Prospective Observational Multicenter Registry Study to Assess the Impact and Long-Term Outcomes of 68Ga-PSMA-11 PETCT Imaging Evaluations for Patients with Newly Diagnosed or Suspected Recurrent Prostate Cancer or Are Candidates for Radioligand Therapy for Prostate Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research registry is to understand the real-world use of Illuccix PETCT in prostate cancer and how results from this testing impact patients treatment and prostate cancer journey over time It will follow subjects and the diagnostic testing and therapy they receive for their prostate cancer
This is an observational research registry Subjects will not be administered any medical diagnostic testing or therapy that they would not have normally undergone outside of participation in the registry
This is an observational research registry Subjects will not be administered any medical diagnostic testing or therapy that they would not have normally undergone outside of participation in the registry
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None